Your browser doesn't support javascript.
loading
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape.
Boniolo, Fabio; Hoffmann, Markus; Roggendorf, Norman; Tercan, Bahar; Baumbach, Jan; Castro, Mauro A A; Robertson, A Gordon; Saur, Dieter; List, Markus.
  • Boniolo F; Present address: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hoffmann M; Present address: Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Roggendorf N; Big Data in BioMedicine Group, Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising 85354, Germany.
  • Tercan B; Chair of Translational Cancer Research and Institute of Experimental Cancer Therapy, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich 81675, Germany.
  • Baumbach J; Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, Heidelberg 69120, Germany.
  • Castro MAA; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Ismaninger Str. 22, Munich 81675, Germany.
  • Robertson AG; Big Data in BioMedicine Group, Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising 85354, Germany.
  • Saur D; Institute for Advanced Study, Technical University of Munich, Garching 85748, Germany.
  • List M; Present address: National Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, MD 20892, USA.
Bioinformatics ; 39(5)2023 05 04.
Article en En | MEDLINE | ID: mdl-37084275
ABSTRACT
MOTIVATION Cancer is one of the leading causes of death worldwide. Despite significant improvements in prevention and treatment, mortality remains high for many cancer types. Hence, innovative methods that use molecular data to stratify patients and identify biomarkers are needed. Promising biomarkers can also be inferred from competing endogenous RNA (ceRNA) networks that capture the gene-miRNA gene regulatory landscape. Thus far, the role of these biomarkers could only be studied globally but not in a sample-specific manner. To mitigate this, we introduce spongEffects, a novel method that infers subnetworks (or modules) from ceRNA networks and calculates patient- or sample-specific scores related to their regulatory activity.

RESULTS:

We show how spongEffects can be used for downstream interpretation and machine learning tasks such as tumor classification and for identifying subtype-specific regulatory interactions. In a concrete example of breast cancer subtype classification, we prioritize modules impacting the biology of the different subtypes. In summary, spongEffects prioritizes ceRNA modules as biomarkers and offers insights into the miRNA regulatory landscape. Notably, these module scores can be inferred from gene expression data alone and can thus be applied to cohorts where miRNA expression information is lacking. AVAILABILITY AND IMPLEMENTATION https//bioconductor.org/packages/devel/bioc/html/SPONGE.html.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / MicroARNs / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / MicroARNs / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article